-- 
Actelion Gains in Zurich After Dropping Macitentan

-- B y   P a u l   V e r s c h u u r
-- 
2011-08-29T07:10:41Z

-- http://www.bloomberg.com/news/2011-08-29/actelion-gains-in-zurich-after-dropping-macitentan-correct-.html
(Correcting direction of shares in first paragraph)  Actelion Ltd. (ATLN)  gained 2.6 percent in
Zurich trading after the company announced itâ€™s dropping
development of its macitentan drug for idiopathic pulmonary
fibrosis.  At 9:01 a.m., Actelion was 83 centimes higher at 33.33
Swiss francs.  To contact the reporter on this story:
Paul Verschuur in Zurich at 
 pverschuur@bloomberg.net   To contact the editor responsible for this story:
Angela Cullen at 
 acullen8@bloomberg.net  